Editorial:Metabolic, Pathological, and Therapeutic Perspectives Intracellular 5’-Nucleotidases.

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|34|4203-4204

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.34, 2013-11, pp. : 4203-4204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

5’-Nucleotidases, Nucleosides and their Distribution in the Brain: Pathological and Therapeutic Implications

By  

Current Medicinal Chemistry, Vol. 20, Iss. 34, 2013-11 ,pp. : 4217-4240

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Soluble 5’-Nucleotidases in the Conversion of Nucleotide Analogs: Metabolic and Therapeutic Aspects

By  

Current Medicinal Chemistry, Vol. 20, Iss. 34, 2013-11 ,pp. : 4249-4259

Bentham Science Publishers

Access to resources Recommend Favorite

The Functional Logic of Cytosolic 5’-Nucleotidases.

By  

Current Medicinal Chemistry, Vol. 20, Iss. 34, 2013-11 ,pp. : 4205-4216

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Therapeutic Advances and their Biomedical Perspectives

By  

Current Drug Metabolism, Vol. 18, Iss. 10, 2018-01 ,pp. : 878-878

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Phosphodiesterase 5 Inhibitors: Pharmacology and Therapeutic Perspectives (Executive Editor: Giuseppe Barbaro)]

By  

Current Pharmaceutical Design, Vol. 12, Iss. 27, 2006-09 ,pp. : 3437-3437

Bentham Science Publishers

Access to resources Recommend Favorite